27007-53-0

Basic information

• Product Name: METHYL 2-BROMO-5-CHLOROBENZOATE
• Synonyms: 2-BROMO-5-CHLOROBENZOIC ACID METHYL ESTER;METHYL 2-BROMO-5-CHLOROBENZOATE;2-bomo-5-chlorobenzoic acid methyl ester;Methylz-Bromo-5-Chlorobenzoate
• CAS NO: 27007-53-0
• Molecular Formula: C₈H₆BrClO₂
• Molecular Weight: 249.49
• EINECS: 1592732-453-0
• Product Categories: Aromatic Esters;Acids & Esters;Bromine Compounds;Chlorine Compounds
• Mol File: 27007-53-0.mol
• Article Data: 21

Chemical Properties

• Melting Point: 37-40°C
• Boiling Point: 278.4 °C at 760 mmHg
• Flash Point: 122.2 °C
• Appearance: /
• Density: 1.604g/cm³
• Vapor Pressure: 0.00427mmHg at 25°C
• Refractive Index: 1.564
• Storage Temp.: Sealed in dry,Room Temperature
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: METHYL 2-BROMO-5-CHLOROBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-BROMO-5-CHLOROBENZOATE(27007-53-0)
• EPA Substance Registry System: METHYL 2-BROMO-5-CHLOROBENZOATE(27007-53-0)

Safety Data

• Hazard Codes: Xi
• Statements: 20/22-36/37/38
• Safety Statements: 36/37/39-45-37-26
• Hazardous Substances Data: 27007-53-0(Hazardous Substances Data)

Usage

Chemical Properties

Colorless liquid

Uses

Methyl 2-bromo-5-chlorobenzoate is used as pharmaceutical intermediate.

InChI:InChI=1/C8H6BrClO2/c1-12-8(11)6-4-5(10)2-3-7(6)9/h2-4H,1H3

Upstream product

• 21739-93-5 2-bromo-5-chlorobenzoic acid 
• 74-88-4 methyl iodide 
• 56961-26-3 2-bromo-3-chlorobenzoic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 77-78-1 dimethyl sulfate 
• 79-37-8 oxalyl dichloride 
• 67-56-1 methanol 

Downstream Products

• 131001-88-2 methyl 2-ethenyl-5-chlorobenzoate 
• 60666-70-8 2-bromo-5-chlorobenzyl alcohol 
• 866625-02-7 5-chloro-2-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzoic acid methyl ester 
• 942273-38-3 methyl 5-chloro-2-((trimethylsilyl)ethynyl)benzoate 
• 1254709-95-9 trideuteromethyl 2-bromo-5-chlorobenzoate 
• 1254709-92-6 methyl 5-chloro-2-(2-naphthyl)benzoate 
• 1301225-15-9 C₁₅H₉BrCl₂O₂ 
• 1301225-14-8 C₁₅H₁₀BrClO₂ 
• 10420-73-2 6-chloroflavone 
• 1301225-13-7 C₁₆H₁₂BrClO₂ 
• 1301225-21-7 C₁₀H₈BrClO₂ 
• 1301225-22-8 C₁₁H₁₀BrClO₂ 
• 1301225-17-1 C₁₆H₁₂BrClO₃ 
• 63046-14-0 6-chloro-2-(4-methoxy-phenyl)-chromen-4-one 

Relevant articles and documents

2, 4, 7-trisubstituted fluorene compound and electronic device thereof

The invention provides a 2, 4, 7-trisubstituted fluorene compound and an electronic device thereof. According to the 2, 4, 7-trisubstituted fluorene compound disclosed by the invention, a fluorene rigid structure is introduced, so that the 2, 4, 7-trisubstituted fluorene compound is excellent in film-forming property and thermal stability, and can be used for preparing an organic light-emitting device, an organic field effect transistor and an organic solar cell. In addition, the 2, 4, 7-trisubstituted fluorene compound can be used as a constituent material of a hole injection layer, a hole transport layer, a light emitting layer, an electron blocking layer, a hole blocking layer or an electron transport layer, and can reduce driving voltage, improve efficiency and brightness, prolong theservice life and the like. The preparation method of the 2, 4, 7-trisubstituted fluorene compound is simple, raw materials are easy to obtain, and industrial development requirements can be met.

Vitamin Catalysis: Direct, Photocatalytic Synthesis of Benzocoumarins via (-)-Riboflavin-Mediated Electron Transfer

An operationally simple protocol is disclosed to facilitate entry to benzo-3,4-coumarins directly from biaryl carboxylic acids without the need for substrate prefunctionalization. Complementary to classic lactonization strategies, this disconnection relies on the oxidation competence of photoactivated (-)-riboflavin (vitamin B2) to generate the heterocyclic core via photoinduced single electron transfer. Collectively, the inexpensive nature of the catalyst, ease of execution, and absence of external metal additives are a convincing endorsement for the incorporation of simple vitamins in contemporary catalysis.

HALO-SUBSTITUTED PIPERIDINES AS OREXIN RECEPTOR MODULATORS

The present application relates to certain halo-substituted piperidine compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating substance addiction, panic disorder, anxiety, post-traumatic stress disorder, pain, depression, seasonal affective disorder, an eating disorder, or hypertension.